Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2025International Journal of Pharmaceutical Sciences and Medicine

CRISPR-Cas9 PROTEIN: PHARMACEUTICAL FRONTIERS IN GENETIC RESTORATION

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSatish Babu RajulapatiMGM GunaseelanRJR Jothika

Discussion

Loading...

Member takes

Overview

This review examines CRISPR-Cas9 gene editing, highlighting its therapeutic prospects in oncology and hereditary conditions.

Key Points

  • CRISPR-Cas9 shows significant therapeutic potential in oncology, inactivating oncogenes and enhancing treatments.
  • Key applications include treating inherited disorders like beta-thalassemia and sickle cell anemia, presenting hopeful results.
  • Assessment of viral and non-viral delivery methods reveals innovations like lipid nanoparticles and DNA nanocarriers.
  • Ongoing challenges such as off-target effects must be addressed, while new techniques like base editing may offer solutions.

Cite This Study

Rajulapati et al. (2025) studied this question.

synapsesocial.com/papers/68af2d83cf1dd9ea359e5b83https://doi.org/10.47760/ijpsm.2025.v10i08.002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<scp>CRISPR</scp> Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential2025 · 12 citations
  2. 2Challenges and Opportunities in the Application of CRISPR-Cas9: A Review on Genomic Editing and Therapeutic Potentials2025 · 27 citations
  3. 3Recent applications, future perspectives, and limitations of the CRISPR-Cas system2025 · 31 citations
  4. 4CRISPR-Cas9 in Pharmaceutical Research: Applications, Challenges, Ethical Considerations and Future Directions2025 · 7 citations
  5. 5Expanding the CRISPR/Cas toolkit: applications in proteomics and theranostics2025 · 1 citations